Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03441126 · ClinicalTrials.gov registry record

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

A clinical trial, sponsored by Johns Hopkins University.

Completed
Registry status
15
Enrollment target

NCT03441126: Completed study, sponsored by Johns Hopkins University.

NCT03441126 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03441126 has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
15 participants
Enrollment target

Study Summary

This study will test the hypothesis that reliable implementation of an evidence-based clinical practice guideline for evaluation of patients with signs and symptoms of sepsis will decrease antibiotic use in pediatric intensive care units (PICUs).

Primary Outcome

The primary outcome of interest is blood culture rate in participating PICUs. A blood culture will be defined as any blood culture processed by the clinical microbiology laboratory.

Interventions

  • OTHER Multicenter Quality Improvement program

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2018-04-01
Est. Completion 2021-12-28
Johns Hopkins University

1,448 total trials

What the finished NCT03441126 record still lists

NCT03441126 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Multicenter Quality Improvement program is the first listed.

NCT03441126 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03441126 about?

NCT03441126 is a clinical study titled "Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children". This study will test the hypothesis that reliable implementation of an evidence-based clinical practice guideline for evaluation of patients with signs and symptoms of sepsis will decrease antibiotic use in pediatric intensive care units (PICUs).

What is the current status of trial NCT03441126?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-04-01. Estimated completion is 2021-12-28.

What interventions are being tested in trial NCT03441126?

The interventions under investigation include: Multicenter Quality Improvement program (OTHER).

Who is sponsoring clinical trial NCT03441126?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03441126, the US trial registry maintained by the National Library of Medicine. NCT03441126 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.